Logo image of SN-H.CA

SENNEN POTASH CORP (SN-H.CA) Stock Fundamental Analysis

Canada - TSX-V:SN-H - CA81723C3075 - Common Stock

0.03 CAD
+0 (+20%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

0

Taking everything into account, SN-H scores 0 out of 10 in our fundamental rating. SN-H was compared to 29 industry peers in the Chemicals industry. Both the profitability and financial health of SN-H have multiple concerns. SN-H does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SN-H has reported negative net income.
SN-H had a negative operating cash flow in the past year.
SN-H had negative earnings in each of the past 5 years.
SN-H had a negative operating cash flow in each of the past 5 years.
SN-H.CA Yearly Net Income VS EBIT VS OCF VS FCFSN-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 -200K -400K -600K

1.2 Ratios

With a Return On Assets value of -1805.06%, SN-H is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -1805.06%
ROE N/A
ROIC N/A
ROA(3y)-2184.17%
ROA(5y)-1474.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SN-H.CA Yearly ROA, ROE, ROICSN-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SN-H so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SN-H.CA Yearly Profit, Operating, Gross MarginsSN-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for SN-H remains at a similar level compared to 1 year ago.
SN-H has a worse debt/assets ratio than last year.
SN-H.CA Yearly Shares OutstandingSN-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
SN-H.CA Yearly Total Debt VS Total AssetsSN-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 200K 400K 600K

2.2 Solvency

SN-H has an Altman-Z score of -6026.00. This is a bad value and indicates that SN-H is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SN-H (-6026.00) is worse than 89.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6026
ROIC/WACCN/A
WACCN/A
SN-H.CA Yearly LT Debt VS Equity VS FCFSN-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 -500K -1M -1.5M -2M

2.3 Liquidity

SN-H has a Current Ratio of 0.00. This is a bad value and indicates that SN-H is not financially healthy enough and could expect problems in meeting its short term obligations.
SN-H's Current ratio of 0.00 is on the low side compared to the rest of the industry. SN-H is outperformed by 89.29% of its industry peers.
SN-H has a Quick Ratio of 0.00. This is a bad value and indicates that SN-H is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.00, SN-H is doing worse than 89.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
SN-H.CA Yearly Current Assets VS Current LiabilitesSN-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

SN-H shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.09%, which is quite impressive.
EPS 1Y (TTM)62.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SN-H. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SN-H.CA Price Earnings VS Forward Price EarningsSN-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SN-H.CA Per share dataSN-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SN-H!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENNEN POTASH CORP

TSX-V:SN-H (10/16/2025, 7:00:00 PM)

0.03

+0 (+20%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.63M
Revenue(TTM)N/A
Net Income(TTM)-142600
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1805.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2184.17%
ROA(5y)-1474.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z -6026
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y68.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.69%
OCF growth 3YN/A
OCF growth 5YN/A

SENNEN POTASH CORP / SN-H.CA FAQ

What is the ChartMill fundamental rating of SENNEN POTASH CORP (SN-H.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to SN-H.CA.


What is the valuation status for SN-H stock?

ChartMill assigns a valuation rating of 0 / 10 to SENNEN POTASH CORP (SN-H.CA). This can be considered as Overvalued.


Can you provide the profitability details for SENNEN POTASH CORP?

SENNEN POTASH CORP (SN-H.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for SN-H stock?

The financial health rating of SENNEN POTASH CORP (SN-H.CA) is 0 / 10.